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Abstract
Background: Methionine (Met) residues in proteins can be readily oxidized by reactive oxygen species to Met
sulfoxide (MetO). MetO is a promising physiological marker of oxidative stress and its inefficient repair by MetO
reductases (Msrs) has been linked to neurodegeneration and aging. Conventional methods of assaying MetO
formation and reduction rely on chromatographic or mass spectrometry procedures, but the use of Met-rich
proteins (MRPs) may offer a more streamlined alternative.
Results: We carried out a computational search of completely sequenced genomes for MRPs deficient in cysteine
(Cys) residues and identified several proteins containing 20% or more Met residues. We used these MRPs to
examine Met oxidation and MetO reduction by in-gel shift assays and immunoblot assays with antibodies
generated against various oxidized MRPs. The oxidation of Cys-free MRPs by hydrogen peroxide could be
conveniently monitored by SDS-PAGE and was specific for Met, as evidenced by quantitative reduction of these
proteins with Msrs in DTT- and thioredoxin-dependent assays. We found that hypochlorite was especially efficient
in oxidizing MRPs. Finally, we further developed a procedure wherein antibodies made against oxidized MRPs were
isolated on affinity resins containing same or other oxidized or reduced MRPs. This procedure yielded reagents
specific for MetO in these proteins, but proved to be ineffective in developing antibodies with broad MetO
specificity.
Conclusion: Our data show that MRPs provide a convenient tool for characterization of Met oxidation, MetO
reduction and Msr activities, and could be used for various aspects of redox biology involving reversible Met
oxidation.
Keywords: Methionine, Methionine sulfoxide, Cysteine, Methionine sulfoxide reductase, Protein oxidation and
reduction, Protein repair, Antibodies
Background
Methionine (Met) is a sulfur-containing amino acid that
is particularly susceptible to oxidation by reactive oxygen
species (ROS). Methionine oxidation results in the for-
mation of a mixture of two diastereomeric forms of me-
thionine sulfoxide (MetO), which can be reduced back
to Met by methionine sulfoxide reductases (Msrs) A
(MsrA) and B (MsrB). These enzymes play an important
role in protection of proteins against oxidative stress and
have been implicated in regulation of the aging process.
Insufficient repair of oxidized Met by these enzymes
may alter protein structure and cause protein aggrega-
tion and/or loss of function, accelerating age-associated
diseases [1-10]. Higher levels of MetO and carbonyl
groups in proteins were found in the brains of Alzhei-
mer’s disease patients based on postmortem pathology
analyses [11]. The reversible oxidation of Met residues
may also modulate protein-protein interactions and par-
ticipate in intracellular signaling [12,13]. Thus, identifi-
cation of proteins most susceptible to Met oxidation
may help better understand age-associated diseases and
signaling pathways.
Conventional assays for detection of MetO and
monitoring its reduction rely on HPLC and mass-
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been several reports on the use of antibodies specific for
certain MetO-containing peptides to detect oxidation of
these peptides [13,16]. There is also a report on the use
of antibodies specific for oxidized plant protein DZS18,
enriched for Met residues, to detect MetO in cellular
proteins [17]. While providing new tools and appro-
aches, these studies, as well as our own previous ana-
lyses, have not yet resulted in specific identification of
MetO in proteins under physiological conditions.
In this regard, an important approach in developing
tools for MetO research is the use of Met-rich proteins
(MRPs). Previously, we identified and characterized three
such proteins and developed methods to monitor their
Met oxidation and MetO reduction by SDS-PAGE and
immunoblot assays [18]. In the current work, we de-
scribe four new MRPs, which in addition to Met enrich-
ment have an added benefit of being deficient in
cysteine (Cys), another sulfur-containing amino acid
highly susceptible to oxidation. We report charac-
terization of these proteins and antibodies generated
against MetO forms of these proteins. We further used
these MRPs to examine various features of Met oxida-
tion and repair in proteins.
Methods
Materials. Genomic DNA of Idiomarina loihiensis L2TR
and Saccharophagus degradans 2–40 was kindly pro-
vided by Dr. Maqsudul Alam and Dr. Steven Hutcheson,
respectively. Pseudomonas putida W619 cells [19] were
kindly provided by Dr. Daniel van der Lelie. Expression
constructs for MRP1 and MRP2, mouse MsrA, mouse
MsrB2, and MsrA-MsrB fusion protein (MsrBA) were
previously described [18,20,21]. Msr null strains were
also described previously [22]. Reagents used in this
work were of the highest grade possible.
Computational identification of MRPs
In an initial step of the search procedure, we adopted a
strategy similar to that previously used for identification
of MRPs [18]. Specifically, using in-house scripts, each
protein in the NCBI non-redundant protein dataset
(downloaded from ftp://ftp.ncbi.nih.gov) was scanned for
Met content and protein length. Sequences with Met
content above 20%, length more than 50 amino acids
and pronounced secondary structures, were selected.
Subsequently, Cys content was analyzed for each MRP.
Proteins with more than 20% Met and low number of
Cys (or lacking Cys) were further considered. The MRP
candidates deemed more likely to be soluble were then
selected by manual analysis for further experimental
studies.
Cloning, expression, purification and mass spectrometry
analyses of MRPs
Sequences coding for MRP4 (from codon 23 to stop
codon), MRP5 (from codon 21 to stop codon), and
MRP6 (from codon 21 to stop codon) were PCR-
amplified from the corresponding genomic DNA. MRP3
coding region starting from amino acid 22 was amplified
from mRNA isolated from Zea mays. MRP7 coding
region was amplified from mouse liver mRNA. PCR
products of MRP3-MRP6 were sequenced, digested with
either NdeI and NotI or Nhe1 and Not1 (for MRP4,
MRP6) and cloned into pET21b vector to generate the
constructs coding for proteins with His-tags at the
C-terminus. The PCR product of MRP7 was cloned into
Nde1/Not1 sites of pET28a+ to generate the construct
coding a protein with a His-tag at both N- and C-terminus.
Soluble (MRP1-MRP2, MRP4-MRP7) and insoluble (MRP3)
recombinant MRPs were purified on Talon columns follow-
ing expression in E. coli using a previous procedure [18].
Mass-spectrometry analyses of MRPs were also carried out
as described previously [18].
Oxidation of MRPs by H2O2
Purified MRPs were subjected to controlled oxidation
by various concentrations of H2O2 or other indicated
oxidants, wherein oxidation was monitored by the mo-
bility of proteins on SDS-PAGE gels. To verify that the
s h i f ti nm o b i l i t yw a sd u et oM e to x i d a t i o n ,t h eo x i d i z e d
proteins were subjected to reduction with Msrs in the
presence of DTT or thioredoxin (Trx) as described
below.
Preparation of oxidized MRPs to generate antibodies
specific for oxidized MRPs
Purified MRP3-MRP7 were oxidized with 10–50 mM
H2O2 at room temperature for 12 h, the oxidized pro-
teins subjected to SDS-PAGE analysis to determine the
extent of oxidation, and ESI-MS analyses were carried
out to measure the number of oxidized Met residues.
The conditions that resulted in oxidation of all Met in
proteins (these were slightly different for various MRPs)
were used to prepare oxidized MRPs at large scale for
immunization. Rabbit polyclonal antibodies were pro-
duced by Covance, Inc.
Enrichment of antibodies specific for oxidized MRPs
Affinity columns containing reduced or oxidized MRP
were used to enrich polyclonal antibodies specific for
oxidized MRPs. To prepare an MRP affinity column,
2–6 mg of a reduced or oxidized MRP (the same prepar-
ation as that used for immunization) were coupled to
NHS-activated Sepharose (GE Life Science, Piscataway,
NJ) according to manufacturer’s instructions. The anti-
body purification procedure included the following two
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first purified on a protein G Sepharose column (GE Life
Science, Piscataway, NJ), and then the resulting IgG frac-
tion (10–20 mg) was dialyzed against PBS and further
applied to a column containing a reduced MRP at room
temperature for 2 h, with shaking. The unbound fraction
was collected and the Sepharose column was washed
with 5 volumes of PBS, followed by elution of the bound
antibodies. The unbound and wash fractions were re-
purified on the column with reduced MRP twice using
the same procedure. The final unbound and wash frac-
tions were used for immunoblot analyses to examine
specificity of the resulting antibodies. (ii) Two-step
enrichment. The final unbound and wash fractions
obtained by the procedure described above were further
purified on the affinity columns containing oxidized
MRPs and the bound antibodies were eluted and used
for further immunoblot analyses.
Msr activity assays using MRPs
The DDT-dependent assay was carried out as following:
2–4 μg of an oxidized MRP were incubated with 5 mM
DTT and 0.5-4 μM Msrs at 37°C for 2 h, and the
reaction mixture was mixed with SDS-PAGE sample
buffer and subjected to SDS-PAGE analysis. The Trx-
dependent assay was as follows: 2–4 μg of an oxidized
MRP were incubated with 6.8 μM Trx, 0.2 μM NADPH,
and 0.4 μM Trx reductase at 37°C for 2 h, and the reac-
tion was subjected to SDS-PAGE analysis.
Results
Computational identification of MRPs
The three first-generation MRPs characterized in our
previous work [18] contained Cys residues, which either
interfered with some redox assays that targeted Met
oxidation and MetO reduction, or required an additional
blocking step prior to MetO analyses. To address this
issue, we conducted a computational search for MRPs
that had few or no Cys residues. An analysis of the NCBI
non-redundant protein database, which also included
ORFs encoded in completely sequenced genomes, rev-
ealed approximately 170 sequences with more than 20%
Met content (10 fold higher Met content than expected
by chance based on Met content of proteins in the NCBI
database), which were present in organisms ranging
from bacteria to mammals. These proteins were further
analyzed for Cys content and secondary structure com-
position. We selected proteins expected to be soluble
based on their predicted secondary structure or modeled
3D structures, and which in addition showed a maximal
Met content and few or no Cys residues. The final set of
MRPs selected based on this procedure had 21-33% Met
and 0-2% Cys (Table 1).
Preparation of recombinant MRPs
For experimental analyses of MRPs, we selected two
proteins from a previous study, including FeNos (herein
designated MRP1) from Nostoc sp, and LegP (herein
designated MRP2) from Legionella. Recombinant MRP1
contained 15 Cys residues and MRP2 a single Cys resi-
due. Both proteins were prepared as His-tag forms and
found to be soluble. The new MRPs included DZS18
(here designated MRP3), a previously characterized stor-
age protein from Zea mays [17], and three hypothetical
proteins from Pseudomonas putida W619 (designated
MRP4), Idiomarina loihiensis L2TR (MRP5), and Sac-
charophagus degradans 2–40 (MRP6). In addition, we
analyzed calmodulin, a calcium sensor protein that con-
tains regulatory Met residues [23]. Mouse calmodulin
(designated MRP7) had 7% Met, so even though its Met
content was below 20%, it was much higher than the
average Met content of proteins (~2%). The four
expressed proteins, MRP3-MRP6, were prepared in the
forms that lacked predicted N-terminal signal peptides
(20–22 amino acids). With regard to Cys content, MRP3
had 3 Cys residues, whereas all other new MRPs lacked
Cys. These proteins could be expressed and isolated
using standard procedures with a high degree of purity
(Figure 1).
Table 1 MRPs characterized in this study
Protein Organism Accession
number
# of Met residues * % of
Met
# of Cys residues* % of Cys
Hypothetical protein (FeNos, MRP1) Nostoc sp. PCC 73102 ZP_00345849 41 (38) 33 15 (15) 12
Hypothetical protein (LegP, MRP2) Legionella pneumophila YP_095088 37 (35) 25 2 (1) 1
Delta zein structural18 (DZS18, MRP3) Zea mays NP_001105054 50 (49) 24 4 (3) 2
Hypothetical protein (MRP4) Pseudomonas putida W619 YP_001746901 32 (31) 21 1 (0) 1
Hypothetical protein (MRP5) Idiomarina loihiensis L2TR YP_155605 32 (31) 22 0 (0) 0
Hypothetical protein (MRP6) Saccharophagus degradans 2-40 YP_527410 36 (35) 25 0 (0) 0
Calmodulin (MRP7) Mus musculus NP_031615 10 (12) 7 0 (0) 0
* Numbers correspond to the number of indicated amino acids encoded in the ORF, and the numbers in brackets correspond to the amino acid residues present
in recombinant MRPs (difference is due to removal of signal peptides).
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reduction by SDS-PAGE
We previously demonstrated that oxidation of Met resi-
dues in the first-generation, Cys-containing MRPs could
be monitored by protein mobility shift using SDS-PAGE
gels, and that MetO-containing MRPs migrated slower
than the corresponding reduced proteins [18]. To fur-
ther examine the utility of SDS-PAGE analysis for moni-
toring MRP oxidation, we oxidized 60 μM MRP1 with
different concentrations of H2O2 and for various periods
of time. The as-isolated and oxidized forms of MRP1
were resolved on 10% SDS-PAGE gels and visualized
by Coomassie blue staining (Figure 2A). Migration of
MRP1 only slightly changed when the protein was incu-
bated with 1 mM or less H2O2 for 7–12 h, whereas it
migrated significantly slower at higher H2O2 concen-
trations. Moreover, mobility of MRP1 proportionally
decreased with the increase in H2O2 levels and time of
treatment; the maximal oxidation was achieved by treat-
ing the protein with 10 mM H2O2 for 12 h.
We further examined Met oxidation by H2O2 in other
MRPs by in-gel assays as well as by mass spectrometry.
Met residues could be fully oxidized in MRP2, MRP4,
MRP5, and MRP6 when 60 μM proteins were treated
with 10 mM H2O2 at room temperature for 12 h; how-
ever, 20 mM and 50 mM H2O2 was required to fully
oxidize MRP3 and MRP7, respectively. These data sug-
gest that structural and sequence context in which Met
is present may influence efficiency of its oxidation.
Figure 2B shows oxidation of MRP5 as monitored by in-
gel assays, and Figure 2C, for comparison, oxidation of
the same protein as monitored by mass spectrometry.
Following 10 mM H2O2 treatment, the observed mass of
MRP5 increased to that corresponding to the mass of
the fully oxidized MRP containing 31 MetO. Thus, Met
oxidation in MRPs resulted in slower migration of all
MRPs on SDS-PAGE gels, indicating that this is a gen-
eral feature of Met oxidation.
Met residues are sensitive to two-electron oxidants
To examine sensitivity of Met residues to different oxi-
dants, we treated 20 μM MRP5 with H2O2 or NaOCl,
which are two-electron oxidants, and with CuSO4 or
FeCl3, which are one-electron oxidants. Treatment of
MRP5 for 1 h at 37°C oxidized approximately 50% Met
residues when 10 mM H2O2 was used, and full oxidation
was achieved upon treatment with 50 mM H2O2. Fur-
ther increase in H2O2 levels to 100 mM did not change
MRP5 mobility on SDS-PAG gels, but also did not lead
to significant protein degradation (Figure 3A). 1 mM
NaOCl could oxidize this MRP to the same extent as
that caused by the treatment with 10 mM H2O2; how-
ever the amount of oxidized MRP5 decreased when the
protein was treated with 5 mM NaOCl, and the protein
was essentially undetectable after treatment with 10 mM
NaOCl (Figure 3A). Thus, compared with H2O2, NaOCl
is a stronger oxidant of Met in proteins, and at higher
concentrations it can break peptide bonds. The mobility
of MRP5 on SDS-PAGE gels did not change when the
protein was treated with CuSO4 or FeCl3, suggesting
that they are inefficient Met oxidants (Figure 3B).
Analyses of Msr activities by in-gel assays using MRPs as
substrates
We further subjected oxidized MRPs to treatment with
Msr enzymes (Figure 4). MsrA, MsrB or the natural fu-
sion protein containing both MsrA and MsrB domains,
MsrBA, could efficiently reduce MetO in MRPs. For ex-
ample, 4 μg MRP1 required 0.5 μM MsrA or MsrB for
50% reduction (Figure 4A,B) and could be completely
reduced by either MsrBA or a combination of MsrA and
MsrB (Figure 4B,C). We also utilized the same assay to
examine the Trx-dependent Msr activity and found that
Msrs could efficiently use Trx to reduce MRPs. For com-
parison, the reduction of Cys-free MRPs by Msrs was
examined by treatment of oxidized MRP5 with Msrs.
Interestingly, besides a complete reduction of oxidized
MRP5 by Msrs both in DTT- and Trx-dependent assays,
this MRP required less NADPH compared with the re-
duction of MRP1, which contained 15 Cys. The quanti-
tative reduction of MRPs suggested that MsrA and MsrB
could target all MetO in these proteins, although prob-
ably with different efficiency.
Figure 1 SDS-PAGE analysis of recombinant MRPs. His-tagged
recombinant MRPs (MRP1 to MRP7) were identified through a
computational procedure, cloned, expressed in E. coli BL21 cells,
purified on Talon resin, and the purified proteins subjected to SDS-
PAGE analysis and visualized by Coomassie Blue staining. Lanes 1 to
7 correspond to MRP1 to MRP7, respectively.
Liang et al. BMC Biochemistry 2012, 13:21 Page 4 of 10
http://www.biomedcentral.com/1471-2091/13/21Antibodies specific for oxidized MRPs
To generate antibodies recognizing MetO residues, we
optimized large-scale MRP oxidation by following mo-
bility of MRPs on SDS-PAGE gels and carrying out mass
spectrometry analyses. Antibodies were prepared against
all oxidized MRPs, but, as expected, they were found to
recognize both reduced and oxidized forms of these pro-
teins. Therefore, we isolated antibodies on affinity col-
umns containing conjugated reduced MRPs, and the
flow-through fractions from these columns were found
to be enriched for oxidized MRPs. These antibodies were
designated e.g. a-MRP4-OX and a-MRP6-OX, for anti-
bodies enriched for oxidized MRP4 and MRP6, respect-
ively (Figure 5A,B). To examine specificity of the enriched
antibodies to MRP4, the oxidized MRP4 was immuno-
blotted with the corresponding antibodies (Figure 5C),
which was found to only recognize the protein after it was
treated with 2 mM or higher concentrations of H2O2.
Subsequent analyses with reduced and oxidized MRP4
revealed that the antibodies could recognize as little as
20 ng oxidized protein (Figure 5D), whereas the
reduced MRP4 could only be detected when the pro-
tein amounts were increased to 4 μg.
To test if antibodies enriched for certain oxidized MRPs
reacted with other oxidized MRPs, the antibodies enriched
for oxidized MRP4 and MRP6 were used to probe various
MRPs in both oxidized and reduced forms; the enriched
a-MRP4-OX antibodies recognized oxidized MRP2, MRP5
and MRP6, but did not interact with any of the reduced
MRPs (Figure 6A). The enriched antibodies to oxidized
MRP6 recognized oxidized MRP1, MRP2, MRP3, MRP4,
and were unable to detect reduced MRPs. However, non-
enriched antibodies interacted with both reduced and oxi-
dized forms of MRPs (Figure 6B). Similarly, non-enriched
antibodies to MRP3 detected reduced and oxidized MRP4
and MRP6 (Figure 7A). Based on the observed cross re-
activity with MRP4, the antibodies to MRP3 were first ap-
plied to the affinity column containing reduced MRP4, and
the unbound fraction was further fractionated on the col-
umn containing oxidized MRP4; this time the bound and
eluted fraction was collected. These antibodies specifically
recognized oxidized MRP4 generated by treatment
with 5 mM (or higher concentration) H2O2.H o w e v e r ,
they did not detect reduced MRP4 or the same protein
treated with lower H2O2 concentrations (Figure 7B).
Finally, we tested if the resulting antibodies could
recognize MetO-containing proteins in yeast extracts.
The antibodies made against oxidized MRP3 and further
enriched on the MRP4 column (Figure 7B) detected a
62 kDa protein band in the lysate of S. cerevisiae BY4741
Figure 2 Analyses of Met oxidation and MetO reduction in MRPs by SDS-PAGE. (A)6 0μM MRP1 was treated with indicated concentrations
of H2O2 for 7 or 12 h, and protein oxidation was monitored by the mobility shift on SDS-PAGE gels, as visualized by Coomassie Blue staining.
Open triangles represent increasing treatment time (i.e., 7, 12 h). (B)6 0μM MRP5 was oxidized with indicated concentrations of H2O2 at room
temperature for 12 h, and MetO formation was monitored by the mobility shift on SDS-PAGE gels, as visualized by Coomassie Blue staining.
(C) Mass-spectrometry analysis of reduced MRP5 and the protein oxidized by 10 mM H2O2 at room temperature for 12 h. Theoretical and
observed masses are shown.
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knockout lysates treated with H2O2 (Figure 8). However,
this protein band showed similar intensity regardless of
occurrence of Msrs and its intensity did not increase with
the increase in peroxide concentration. We interpret these
data to mean limited utility of MRP antibodies for detec-
tion of MetO in endogenous proteins. We also employed
other approaches, but were not able to generate antibodies
that generally recognize MetO. This finding is consistent
with a recent article that reported that the previously
reported MetO antibodies do not recognize MetO in
proteins [24].
Discussion
In this work, we characterized Met oxidation and MetO
reduction in proteins by SDS-PAGE and immunoblot
analyses using novel, second-generation MRPs as sub-
strates. We also developed antibodies specific for oxi-
dized MRPs that could recognize other oxidized MRPs.
A key feature of new proteins identified and character-
ized in the current study is that they contained more
than 20% Met, while lacking Cys, whose oxidation may
interfere with certain redox assays involving Met oxida-
tion. The use of Cys-free MRPs avoids a complication of
variable oxidation of sulfur-containing amino acids
[25-29]: in new MRPs proteins, all oxidation events
(under relatively mild oxidizing conditions) correspond
to Met oxidation.
Whereas previous studies already showed that Met
oxidation may result in a decreased mobility of proteins
on SDS-PAGE gels, these studies involved a limited
number of proteins, and in some cases, no changes in
mobility were observed. The use of 7 MRPs, as reported
in our study, demonstrates that the decreased mobility
on SDS-PAGE gels is a basic property of Met oxidation.
Since each of the MRPs has many Met residues, these
proteins could be used to monitor Met oxidation and
MetO reduction and to assess the degree of Met oxida-
tion at any given point in the assay.
Interestingly, retardation of migration of oxidized
MRPs on SDS-PAGE gels was more pronounced than
that expected based on the mass difference between
reduced and oxidized proteins. For example, a complete
oxidation of Met residues in MRP1 increased the protein
mass by 0.6 kDa; however, comparison of migration of
this protein with protein standards revealed an apparent
6 kDa shift in mobility. Most Met residues in MRPs
could be oxidized to MetO by treatment with 10 mM
H2O2 for 12 h at room temperature, and there was an
excellent correspondence between mass-spectrometry
and SDS-PAGE analyses. Overall, the use of multiple
MRPs allows us to state that Met oxidation that results
in slower migration of these proteins on SDS-PAGE gels
is a general feature of MRPs, and that it is independent
of the occurrence of Cys in these proteins.
Although our data suggested that all Met residues
could be oxidized by peroxide and targeted for reduction
by Msrs, we observed important differences with regard
to efficiency of these processes. For example, the use of
H2O2 concentrations above 10 mM typically did not fur-
ther change MRP migration on SDS-PAGE gels (because
all Met were already oxidized at this concentration).
However, calmodulin (it contained fewer Met than other
MRPs examined in our study) required approximately
50 mM H2O2 for full oxidation. These data are also
consistent with the observations in a previous report [23]
and suggest a role of protein structure in protecting Met
from oxidation. The sequence context of Met probably
also has an effect on Met oxidation in this protein.
The conversion of Met to MetO involves a two-
electron oxidation process [30,31]. We further employed
MRPs to assess Met oxidation upon treatment with sev-
eral one- and two-electron oxidants. MRP5 was insensi-
tive to oxidation by CuSO4 and FeCl3, and the mobility
of MRP2 also did not change when it was treated with
25 μM CuCl2 and 25 mM ascorbate for 1 h. With regard
to two-electron oxidants, H2O2 being a milder oxidant
was more specific than NaOCl in oxidizing Met, whereas
Figure 3 Oxidation of Met in MRPs by various oxidants. 20 μM
MRP5 was oxidized with the indicated concentrations of (A)
hydrogen peroxide (H2O2) or sodium hypochlorite (NaOCl) at 37°C
for 1 h; (B) CuSO4 or FeCl3 at 37°C for 2 h, and then subjected to
SDS-PAGE analysis.
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generates HOCl, which is a strong microbicidal agent,
capable of killing bacteria, fungi and viruses, and it can
modify various residues in proteins, especially Cys, Met,
Trp, and Tyr [32,33]. Protein carbonyls can subsequently
be generated from chloramines via the loss of HCl and
hydrolysis of the amine [34]. We found that at the ratio
of NaOCl to MRP 50:1, most Met residues in MRP5
were oxidized. However, when the ratio increased to 250
fold, the amount of MRP5 decreased due to protein
degradation. Thus, MRPs are a convenient tool for
examining specificity and efficiency of Met oxidation in
proteins.
Another application of MRPs is the use of these pro-
teins as substrates in Msr activity assays. We previously
found that oxidized MRPs can be reduced by Msrs in a
DTT-dependent assay. In the current work, we utilized
Trx-dependent reactions involving MsrA, MsrB and a
fusion protein MsrBA and found that this assay is
equally amenable to the analysis of MetO reduction in
MRPs.
Protein state- and modification-specific antibodies,
both monoclonal and polyclonal, have been a great in-
strument in protein analysis, and this especially applies
to phosphorylation state-specific antibodies [35]. These
reagents opened many exciting opportunities in sig-
naling and regulation studies as well as in diagnostic
pathology. Since MetO chemically differs from Met, an
attractive possibility is to develop antibodies specific for
MetO-containing proteins. However, previous antibodies
that recognize MetO have been limited to certain MetO-
containing peptides [13,16]. One difficulty in preparing
MetO-specific antibodies is that MetO residues in the
antigen may be reduced back to Met in the immunized
Figure 4 Msr activity assays by following MRP electrophoretic mobility shift on SDS-PAGE gels. 4 μg of as-isolated (lane 1) or oxidized
(lanes 2 to 12) MRP1 were incubated with Msrs and DTT or Trx as described in Materials and Methods, electrophoresed on 10% SDS-PAGE gels
and stained with Coomassie Blue. Migration of reduced (R) and oxidized (O) MRP1 is shown by arrows. (A) MsrA activity assay. (B) MsrB activity
assay (lanes 2 to 11) and MsrA plus MsrB activity assay (lane 12). (C) MsrBA activity assay. When used separately, MsrA and MsrB partially reduced
oxidized Met residues, whereas treatment with MsrBA completely restored mobility of the reduced protein.
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MRPs examined in the current study, we found that the
original antisera against MRP3, MRP4 and MRP6 could
be enriched for fractions specific for their respective
MetO-containing forms by trapping the antibodies that
bind the reduced forms of MRPs. We further purified
the antibodies on the columns containing other cross-
linked oxidized MRPs. The resulting antibodies recog-
nized other MetO-containing proteins.
We tested a potential application of detecting MetO
residues in proteins with the antibodies against various
MRPs. MRP3 antibodies enriched on the resin with the
oxidized MRP4 could recognize a 62 kDa protein band
in yeast lysates treated with H2O2. Since this protein was
weakly detected by the same batch of antibodies in the
sample not treated with H2O2, we reasoned that it is
sensitive to oxidation. Previously developed antibodies
against MRP3 [17] also detected a protein (estimated
Figure 5 Immunodetection of MRP in as-isolated and oxidized
forms with antibodies enriched for the corresponding oxidized
MRPs. (A, B)2μg of MRPs (as-isolated and oxidized forms) were
resolved on SDS-PAGE gels, transferred onto PVDF membranes, and
analyzed by Western blot assays with the antibodies against
indicated oxidized MRPs. Top panel: Polyclonal antiserum (non-
enriched) used to detect oxidized MRP4 (A) or MRP6 (B). Middle
panel: Polyclonal antiserum against oxidized MRPs was purified on
an affinity column containing reduced MRP, and the unbound
fraction (designated enriched) was found to be enriched for the
antibodies specific for the oxidized MRPs. Bottom panel: protein
loading. “R” indicates reduced and “O” indicates oxidized MRPs.
(C)2μg of MRP4 were oxidized with indicated concentrations of H2O2
for 12 h at room temperature and detected with non-enriched (top
panel) or enriched (bottom panel) antibodies for oxidized MRP4 by
Western blot analysis. (D) Western blot analysis of different amounts of
MRP4 oxidized with 10 mM H2O2 for 12 h at room temperature with
non-enriched and enriched antibodies for oxidized MRP4. Triangles
represent increasing amounts of MRP loading (0.25, 0.5, 1, 2 and 4 μg).
“MRP4-R” indicates the as-isolated MRP4 (lanes 1 to 5), and “MRP4-O”
indicates the oxidized MRP4 (lanes 6 to 10).
Figure 6 Antibodies enriched for the oxidized MRPs recognize
other oxidized MRPs. Western blot analysis of as-isolated (MRP-R;
R for reduced) and oxidized (MRP-O; O for oxidized) MRPs (MRP1-
MRP7) with initial antisera raised against oxidized proteins (top
images in each panel) and enriched antibodies (bottom images in
each panel). (A) Antibodies against oxidized MRP4. (B) Antibodies
against oxidized MRP6.
Figure 7 Enrichment of antibodies for certain oxidized MRPs
using affinity columns with other MRPs. (A) Western blot analysis
of as-isolated and oxidized (10 mM H2O2, 12 h) MRP4 and MRP6
with antiserum against oxidized MRP3. “R” indicates as-isolated (i.e.,
reduced) protein, and “O” indicates oxidized protein. (B) Polyclonal
antiserum against MRP3 was first purified on a protein G column,
then fractionated on an affinity column with as-isolated MRP4, and
the unbound fraction was further purified on a column with
oxidized MRP4. The bound fraction from the latter column was used
for detection of MRP4 oxidized under various H2O2 treatment
conditions.
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However, in our hands, this band was not regulated by
MsrA/MsrB status and was not increased by treatment
with higher concentration of peroxide. More generally,
none of the antibodies we developed were able to gen-
erally recognize MetO in proteins. This is also consist-
ent with a recent report [24].
Conclusions
MRPs represent a convenient tool to study Met oxida-
tion and MetO reduction. These proteins and antibodies
against them could be used in a variety of applications,
several of which are highlighted in our study. MetO
can be formed under physiological conditions in cells,
but due to low abundance of Met residues and their
random oxidation, the analyses of Met oxidation and
MetO reduction have been difficult. With the second-
generation MRP tools, some of the outstanding ques-
tions in Met oxidation and MetO reduction processes
can be addressed.
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